Resistin is expressed in the human placenta

Area of Science:

• Endocrinology
• Reproductive Biology
• Metabolism

Background:

• Insulin resistance is common in pregnancy but its mechanisms are not fully understood.
• Resistin, a peptide hormone from adipose tissue, reduces insulin sensitivity in rodents.
• The role of resistin in human pregnancy is currently unclear.

Purpose of the Study:

• To investigate the presence and localization of resistin gene expression in human placental tissue.
• To compare resistin gene expression in placental tissue during different stages of pregnancy.
• To assess resistin gene expression in maternal adipose tissue during pregnancy.

Main Methods:

• Real-time quantitative PCR was used to measure resistin gene expression.
• Immunohistochemistry was employed to determine the cellular localization of resistin in placental tissue.
• Samples were collected from first trimester chorionic tissue and term placental tissue, as well as maternal adipose tissue.

Main Results:

• Resistin gene expression was detected in human placental tissue, primarily in trophoblastic cells.
• Resistin gene expression was significantly higher in term placental tissue compared to first trimester chorionic tissue.
• Resistin gene expression in maternal adipose tissue was low and not significantly altered by pregnancy.

Conclusions:

• Resistin is identified as a novel placental hormone in humans.
• Resistin may play a role in modulating insulin sensitivity during human pregnancy.
• Further research is warranted to elucidate the precise function of placental resistin in pregnancy.